Author
Listed:
- Manabu Itoh
(Saga University)
- Yosuke Mukae
(Saga University)
- Takahiro Kitsuka
(Saga University)
- Kenichi Arai
(Saga University)
- Anna Nakamura
(Saga University)
- Kazuyoshi Uchihashi
(National Hospital Organization Saga Hospital)
- Shuji Toda
(Saga University)
- Kumika Matsubayashi
(Cyfuse Biomedical K. K.)
- Jun-ichi Oyama
(Saga University)
- Koichi Node
(Saga University)
- Daisuke Kami
(Kyoto Prefectural University of Medicine)
- Satoshi Gojo
(Kyoto Prefectural University of Medicine)
- Shigeki Morita
(National Hospital Organization Kyushu Medical Center)
- Takahiro Nishida
(Saga University)
- Koichi Nakayama
(Saga University)
- Eiji Kobayashi
(Keio University School of Medicine)
Abstract
Before they are used in the clinical setting, the effectiveness of artificially produced human-derived tissue-engineered medical products should be verified in an immunodeficient animal model, such as severe combined immunodeficient mice. However, small animal models are not sufficient to evaluate large-sized products for human use. Thus, an immunodeficient large animal model is necessary in order to properly evaluate the clinical efficacy of human-derived tissue-engineered products, such as artificial grafts. Here we report the development of an immunodeficient pig model, the operational immunodeficient pig (OIDP), by surgically removing the thymus and spleen, and creating a controlled immunosuppressive protocol using a combination of drugs commonly used in the clinical setting. We find that this model allows the long-term accommodation of artificial human vascular grafts. The development of the OIDP is an essential step towards a comprehensive and clinically relevant evaluation of human cell regeneration strategies at the preclinical stage.
Suggested Citation
Manabu Itoh & Yosuke Mukae & Takahiro Kitsuka & Kenichi Arai & Anna Nakamura & Kazuyoshi Uchihashi & Shuji Toda & Kumika Matsubayashi & Jun-ichi Oyama & Koichi Node & Daisuke Kami & Satoshi Gojo & Shi, 2019.
"Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes,"
Nature Communications, Nature, vol. 10(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10107-1
DOI: 10.1038/s41467-019-10107-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10107-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.